These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Is resection of left-sided ductal pancreatic carcinoma of value?]].
    Author: Gebhardt C, Meyer W, Jurowich C.
    Journal: Zentralbl Chir; 2000; 125(12):966-9. PubMed ID: 11190614.
    Abstract:
    UNLABELLED: The ductal adenocarcinoma of the left part of the pancreas is concerned to be incurable. With the aid of the own patient material and the data from the literature an analysis was made to find out whether this negative prognostic assessment can be accepted. METHODS: The findings of 60 patients with tumors in the corpus/cauda region of the pancreas served as a basis for the investigation (observation time: 1986-1998). The resected tumors were reclassified according to the UICC from 1997. The survival rates were calculated with the method of Kaplan-Meier. RESULTS: Only 12 (20%) of the 60 tumors were resectable, in 6 cases only by multivisceral resection. A R0-resection was possible in 8 cases. 11 of these 12 patients had already a lymph vessel invasion (L1) and 50% an involvement of lymph nodes (pN1). After curative resection the median survival time was 17 months, after palliative resection 4 months and in cases with inoperability only 3.6 months. The survival time is identical with the results after operative treatment of carcinomas of the pancreatic head. CONCLUSIONS: Stage related the prognosis of the left sided pancreatic carcinoma is comparable with the results after similar therapy of the pancreatic head carcinoma. Therefore therapeutic nihilism is not indicated.
    [Abstract] [Full Text] [Related] [New Search]